Monday, August 16, 2010


ONTARIO, CA, August 12, 2010 -- Axxess Pharma, Inc. (PINKSHEETSAXXE), a pharmaceutical company specializing in the marketing and distribution of both prescription and non-prescription drugs, announces on June 14, 2010 Taylor Capitol, Inc was hired as Investor Relations to replace Mina Mar Marketing Group.

Axxess Pharma, Inc. closed at $0.013 Friday, trading 332,829 shares.

Axxess Pharma, Inc. Provides Update Regarding Mina Mar Marketing Group

About Axxess Pharma, Inc.

Axxess Pharma, Inc. is a specialty pharmaceutical company that focuses on the marketing of dermatological, therapeutic nutritionals, pain management and diagnostic products in Canada and abroad since 1997. Axxess owns 22 established pharmaceutical prescription products that have proven sales in Canada and internationally. The company has an experienced management team and field sales force to market products nationally to hospitals and retail pharmacies as well as specialized practice areas including Dermatology and Nephrology, Neurology and Urology.

Free AXXE small cap stock news and charts available at http://www.stockprofiler.us/Company/AXXE


-------------------------------------------

FOOTHILL RANCH, CA, August 16, 2010 -- Medical Marijuana Inc (PINKSHEETS: MJNA) is pleased to announce progress as they move toward the launch date of August 28.

Medical Marijuana Inc closed at $0.09 Friday, trading 935,068 shares.

Medical Marijuana Inc Agent Base Continues to Expand With 12 Days Until Launch of "The Hemp Network," the World's First Hemp Product Related Network Marketing Company

About Medical Marijuana Inc.

Medical Marijuana Inc recognizes the vast and unequaled opportunities that exist in the rapidly expanding hemp and medical marijuana industries. The scientific recognition of cannabis has brought legalized marijuana use to the forefront of mainstream discussion, thus opening the door for safe and lucrative investment opportunities.


-------------------------------------------

StockProfiler.US Announcement!

Membership with access to enhanced stock investing tools is now FREE! Claim yours at http://www.stockprofiler.us/Register

Stay connected with StockProfiler.US – Fan up with us on Facebook (keyword: StockProfiler.US) or follow us on Twitter at http://twitter.com/StockProfilerUS

View free small cap company videos and product reviews at our YouTube channel. Visit http://www.youtube.com/StockProfilerUS

-------------------------------------------

About StockProfiler.US:
StockProfiler.US is a media source for publicly traded small cap companies and investors to come together and discover market opportunities. Public companies can effectively broadcast their message to a targeted audience who come to StockProfiler.US seeking an advantage by discovering companies in their startup phase or ones who have yet to be discovered by the investment community.
Call us at (603) 424-4420 or email info@stockprofiler.us
-------------------------------------------

Please Note: All news contained herein has been previously issued by the companies mentioned in this release, and is the property of each company, respectively. All news is edited for content. The companies that are discussed in this opinion have not approved the statements made in this opinion.

This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.

Stock Profiler.US, LLC's News Division includes but is not limited to: http://www.stockprofiler.ushttp://www.associatesfortune.com,
http://www.fastmoneytalk.comhttp://www.markettelegraph.com,http://www.thewallstreetleader.com, and http://www.daytradersdigest.com.

Stock Profiler.US, LLC has been compensated for services rendered; Stock Profiler.US, LLC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.

To view full disclaimers and terms of use, go to http://www.stockprofiler.us/Disclaimer

-------------------------------------------

No comments:

Post a Comment